A287410 Stock Overview
Designs, develops, and manufactures medical device for plastic surgeons, dermatologist, physicians, and healthcare professionals in South Korea and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 4/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Jeisys Medical Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩12,880.00 |
52 Week High | ₩13,800.00 |
52 Week Low | ₩7,390.00 |
Beta | 0.44 |
11 Month Change | -0.15% |
3 Month Change | -0.15% |
1 Year Change | 13.58% |
33 Year Change | 76.44% |
5 Year Change | n/a |
Change since IPO | 203.06% |
Recent News & Updates
Recent updates
Jeisys Medical Inc. (KOSDAQ:287410) Looks Just Right With A 31% Price Jump
May 25Is There An Opportunity With Jeisys Medical Inc.'s (KOSDAQ:287410) 46% Undervaluation?
May 21The Returns On Capital At Jeisys Medical (KOSDAQ:287410) Don't Inspire Confidence
Apr 27Jeisys Medical Inc. (KOSDAQ:287410) Looks Just Right With A 28% Price Jump
Apr 09Shareholder Returns
A287410 | KR Medical Equipment | KR Market | |
---|---|---|---|
7D | 0.2% | -5.9% | 0.9% |
1Y | 13.6% | 21.4% | 3.8% |
Return vs Industry: A287410 underperformed the KR Medical Equipment industry which returned 21.4% over the past year.
Return vs Market: A287410 exceeded the KR Market which returned 3.8% over the past year.
Price Volatility
A287410 volatility | |
---|---|
A287410 Average Weekly Movement | 0.8% |
Medical Equipment Industry Average Movement | 8.1% |
Market Average Movement | 6.8% |
10% most volatile stocks in KR Market | 12.2% |
10% least volatile stocks in KR Market | 3.6% |
Stable Share Price: A287410 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A287410's weekly volatility has decreased from 7% to 1% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 275 | n/a | www.jeisys.com/2016 |
Jeisys Medical Inc. designs, develops, and manufactures medical device for plastic surgeons, dermatologist, physicians, and healthcare professionals in South Korea and internationally. The company offers products for treatment areas, such as skin rejuvenation, lifting/tightening, pigmentation treatments, fat reduction, acne, tattoo removal, and scars and striae distensae under the ULTRAcel Q+ system, Cellec V system, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, SmoothCool, and ULTRAcel brands. It provides its products through a network of distributors.
Jeisys Medical Inc. Fundamentals Summary
A287410 fundamental statistics | |
---|---|
Market cap | ₩959.37b |
Earnings (TTM) | ₩27.97b |
Revenue (TTM) | ₩167.82b |
34.3x
P/E Ratio5.7x
P/S RatioIs A287410 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A287410 income statement (TTM) | |
---|---|
Revenue | ₩167.82b |
Cost of Revenue | ₩50.80b |
Gross Profit | ₩117.03b |
Other Expenses | ₩89.06b |
Earnings | ₩27.97b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 375.50 |
Gross Margin | 69.73% |
Net Profit Margin | 16.67% |
Debt/Equity Ratio | 60.6% |
How did A287410 perform over the long term?
See historical performance and comparison